ELEV; they have no revenue or reasonable prospects of earning a single penny before they burn more cash crushing their stand alone prospects in that category (continuous spending on committed focus to conclusion) ..Value may be a bet on a majority owner buying the shares and using the cash to rollup other Co's, or they mastermind an ideal reverse merger with a better drug Co. with better prospects but short of cash.
Market Data 
Markets 
AI
